Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information

Kaushala Jayawardana*, Sarah Jane Schramm, Lauren Haydu, John F. Thompson, Richard A. Scolyer, Graham J. Mann, Samuel Müller, Jean Yee Hwa Yang

*Corresponding author for this work

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

In patients with metastatic melanoma, the identification and validation of accurate prognostic biomarkers will assist rational treatment planning. Studies based on "-omics" technologies have focussed on a single high-throughput data type such as gene or microRNA transcripts. Occasionally, these features have been evaluated in conjunction with limited clinico-pathologic data. With the increased availability of multiple data types, there is a pressing need to tease apart which of these sources contain the most valuable prognostic information. We evaluated and integrated several data types derived from the same tumor specimens in AJCC stage III melanoma patients-gene, protein, and microRNA expression as well as clinical, pathologic and mutation information-to determine their relative impact on prognosis. We used classification frameworks based on prevalidation and bootstrap multiple imputation to compare the prognostic power of each data source, both individually as well as integratively. We found that the prognostic utility of clinico-pathologic information was not out-performed by any of the various "-omics" platforms. Rather, a combination of clinico-pathologic variables and mRNA expression data performed best. Furthermore, a patient-based classification analysis revealed that the prognostic accuracy of various data types was not the same for different patients. This indicates that ongoing development in the individualized evaluation of melanoma patients must take account of the value of both traditional and novel "-omics" measurements.

Original languageEnglish
Pages (from-to)863-874
Number of pages12
JournalInternational Journal of Cancer
Volume136
Issue number4
DOIs
Publication statusPublished - 15 Feb 2015
Externally publishedYes

Keywords

  • melanoma
  • prognosis
  • biomarkers
  • data integration
  • prevalidation

Fingerprint Dive into the research topics of 'Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information'. Together they form a unique fingerprint.

Cite this